Rossi M E, Azzari C, Resti M, Appendino C, Pezzati P, Vierucci A
Department of Pediatrics, University of Florence, Italy.
Clin Exp Immunol. 1988 May;72(2):196-200.
IgG subclasses of antibodies to the hepatitis B surface antigen (HBsAg) in sera from 40 healthy infants immunized with the vaccine against hepatitis B virus (HBV) were detected using an enzyme-linked immunosorbent assay (ELISA) with monoclonal antibodies. The infants were born to asymptomatic HBsAg-positive mothers. Total serum IgG subclasses were also tested to exclude a deficiency of certain subclasses in these infants but their distribution was the one expected according to age. In contrast, IgG subclass antibodies to HBsAg were predominantly IgG1 and IgG4. The collected data indicate that infants produce significantly higher levels of IgG1 and IgG4 than IgG2 and IgG3 in response to the vaccine for HBV. The IgG4 response to anti-viral vaccinations is uncommon. The role of that IgG4 subclass is not yet clear: even if an anaphylactic role was suggested, no adverse reactions were observed in vaccinated children.
采用酶联免疫吸附测定(ELISA)法,利用单克隆抗体检测了40名接种乙肝病毒(HBV)疫苗的健康婴儿血清中乙肝表面抗原(HBsAg)抗体的IgG亚类。这些婴儿的母亲均为无症状HBsAg阳性。同时检测了血清总IgG亚类,以排除这些婴儿中某些亚类的缺乏,但它们的分布符合预期的年龄分布。相比之下,针对HBsAg的IgG亚类抗体主要为IgG1和IgG4。收集的数据表明,婴儿对HBV疫苗产生应答时,产生的IgG1和IgG4水平显著高于IgG2和IgG3。IgG4对抗病毒疫苗接种的应答并不常见。IgG4亚类的作用尚不清楚:即使有人提出其具有过敏作用,但在接种疫苗的儿童中未观察到不良反应。